ArticleAnnals of translational medicine2021

Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study.

Yang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.